Patents Assigned to KTB Tumorforschungsgesellschaft mbH
  • Receptor and Antigen Targeted Prodrug
    Publication number: 20100111866
    Abstract: The present invention relates to a prodrug which comprises at least one pharmaceutically and/or diagnostically active compound bound by a cleavable linker, a receptor and/or antigen targeting moiety and a protein-binding moiety which is capable of binding to a carrier molecule.
    Type: Application
    Filed: February 15, 2008
    Publication date: May 6, 2010
    Applicant: KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
    Inventor: Felix Kratz
  • Acylgycerophospholipids for treating symptoms concomitant with cancer
    Publication number: 20090298793
    Abstract: The invention relates to the use of acylglycerophospholipids, in particular of hydrogenated acylglycerophospholipids and of phospholipids with a high omega-3 fatty acid content, for the production of a medicament for treating symptoms concomitant with cancer, in particular for treating tumour cachexia, cancer-related problems and pain, and for the prophylaxis of tumour growth and metastasis.
    Type: Application
    Filed: July 24, 2006
    Publication date: December 3, 2009
    Applicant: KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
    Inventor: Ulrich Massing
  • Tablet containing hydrogenated phospholipids
    Publication number: 20080187583
    Abstract: The present invention provides a process for preparing a tablet containing hydrogenated phospholipids and the tablet obtainable by such process.
    Type: Application
    Filed: January 23, 2008
    Publication date: August 7, 2008
    Applicant: KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
    Inventors: Ulrich Massing, Annette Bauer-Brandl
  • Protein-Binding Anthracycline Peptide Derivatives and Drugs Containing Them
    Publication number: 20080161245
    Abstract: The invention pertains to low-molecular anthracycline-peptide derivatives with PSA-cleavable peptide sequences, which contain a protein-binding group.
    Type: Application
    Filed: February 22, 2006
    Publication date: July 3, 2008
    Applicant: KTB Tumorforschungsgesellschaft mbH
    Inventors: Felix Kratz, Da-Eun Chung